targeted cancer therapy

LuciEna 50mg is a targeted therapy used to treat acute myeloid leukemia with IDH2 mutation. It helps restore normal blood cell development and reduces cancer cell growth. This medicine is commonly prescribed in specialized oncology centers across the United Kingdom, United States, Australia, Singapore and Philippines. LuciEna offers a more focused treatment approach improving disease management in patients who may not respond to conventional therapies. Active Ingredient Enasidenib is an IDH2 inhibitor that targets mutated isocitrate dehydrogenase 2 enzyme. It belongs to a class of targeted anticancer agents designed to restore normal cell differentiation. Uses of LuciEna 50mg • Treatment of acute myeloid leukemia • Management of IDH2 mutation cancers • Relief from abnormal blood cell growth • Support for targeted leukemia therapy How LuciEna 50mg Works Enasidenib works by inhibiting the mutated IDH2 enzyme responsible for blocking normal cell maturation. By restoring proper cell differentiation it helps reduce the number of immature cancer cells and improves blood cell production. How to Use LuciEna 50mg 1. Take once daily as directed 2. Swallow with water without crushing 3. Continue treatment as prescribed Possible Side Effects • Nausea • Diarrhea • Fatigue • Elevated bilirubin Precautions • Monitor liver function • Watch for differentiation syndrome • Inform doctor about other treatments Safety Information Use LuciEna only under oncologist supervision. Regular monitoring is necessary to manage side effects and assess treatment response. Storage • Store in a cool dry place • Keep away from light • Keep out of reach of children

LuciOlap 150mg is a targeted cancer treatment used for managing ovarian breast and prostate cancers associated with BRCA mutations. It works by interfering with cancer cell repair mechanisms leading to cell death. This medicine is widely used in oncology care across the United Kingdom, United States, Australia, Singapore and Philippines. LuciOlap provides a personalized treatment approach and is often prescribed when cancer is resistant to standard therapies improving patient outcomes and disease control. Active Ingredient Olaparib is a PARP inhibitor that blocks poly ADP ribose polymerase enzymes involved in DNA repair. It belongs to a class of targeted therapies designed to exploit genetic weaknesses in cancer cells. Uses of LuciOlap 150mg • Treatment of ovarian cancer • Management of breast cancer • Relief from cancer progression • Support for BRCA mutated cancers How LuciOlap 150mg Works Olaparib inhibits PARP enzymes that help repair damaged DNA in cancer cells. When this repair process is blocked cancer cells accumulate damage and eventually die. This targeted action makes it effective for cancers with defective DNA repair pathways. How to Use LuciOlap 150mg 1. Take tablets as prescribed by your doctor 2. Swallow whole with water 3. Maintain consistent dosing schedule Possible Side Effects • Nausea • Fatigue • Anemia • Loss of appetite Precautions • Monitor blood counts regularly • Avoid during pregnancy • Inform doctor about kidney issues Safety Information LuciOlap should be used under strict medical supervision. Follow prescribed dosage and attend regular checkups to monitor effectiveness and safety. Storage • Store at room temperature • Protect from moisture • Keep out of reach of children

LuciTram 2mg is a targeted therapy used to treat melanoma and other cancers associated with BRAF gene mutations. It is often used in combination with other anticancer medicines to enhance effectiveness. This medicine is widely prescribed in oncology practices across the United Kingdom, United States, Australia, Singapore and Philippines. LuciTram helps slow tumor growth and improves survival outcomes by targeting specific molecular pathways involved in cancer progression. Active Ingredient Trametinib is a MEK inhibitor that blocks the MEK enzymes involved in cell division and tumor growth. It belongs to a class of targeted therapies designed to interfere with cancer cell signaling pathways. Uses of LuciTram 2mg • Treatment of melanoma • Management of BRAF mutated cancers • Relief from tumor progression • Support for combination cancer therapy How LuciTram 2mg Works Trametinib works by inhibiting MEK1 and MEK2 enzymes in the MAPK pathway. This pathway plays a crucial role in cancer cell division and survival. By blocking this signaling cascade, it reduces tumor growth and spread. How to Use LuciTram 2mg 1. Take once daily as prescribed 2. Consume on an empty stomach 3. Follow consistent timing each day Possible Side Effects • Diarrhea • Skin rash • Fatigue • Swelling Precautions • Monitor heart and eye health • Avoid during pregnancy • Inform doctor about other medications Safety Information Use LuciTram only under medical supervision. Regular tests are required to ensure safety and effectiveness. Do not stop medication without consulting your doctor. Storage • Store in refrigerator if required • Keep away from light • Keep out of reach of children

LuciDabra 75mg is a targeted anticancer medicine used to treat specific cancers such as melanoma and certain lung cancers that carry a BRAF gene mutation. It works by slowing down or stopping the growth of cancer cells. This medicine is prescribed by oncologists and is widely used in advanced cancer care across the United Kingdom, United States, Australia, Singapore and Philippines. LuciDabra helps improve treatment outcomes when used alone or in combination with other therapies, offering a more precise approach compared to traditional chemotherapy. Active Ingredient Dabrafenib is a BRAF kinase inhibitor belonging to the class of targeted cancer therapies. It specifically blocks abnormal BRAF proteins that promote cancer cell growth. By targeting this mutation, Dabrafenib helps control tumor progression and improves treatment response in eligible patients. Uses of LuciDabra 75mg • Treatment of BRAF mutation positive melanoma • Management of non small cell lung cancer • Relief from cancer progression symptoms • Support for targeted cancer therapy How LuciDabra 75mg Works Dabrafenib works by inhibiting the activity of mutated BRAF protein that signals cancer cells to grow uncontrollably. By blocking this pathway, it slows down tumor growth and reduces the spread of cancer cells. This targeted mechanism allows for more precise treatment compared to general chemotherapy drugs. How to Use LuciDabra 75mg 1. Take the capsule as prescribed by your doctor on an empty stomach 2. Swallow whole with water without crushing or chewing 3. Follow the dosing schedule strictly for best results Possible Side Effects • Fever • Fatigue • Skin rash • Joint pain Precautions • Inform your doctor about any heart or liver conditions • Avoid use during pregnancy unless prescribed • Regular monitoring is required during treatment Safety Information Always take LuciDabra under medical supervision. Do not adjust dosage without consulting your doctor. Regular follow up is essential to monitor response and side effects. Storage • Store at room temperature away from moisture • Keep in original packaging • Keep out of reach of children